Table 1.
PRS and AUCa | Controls, No. | PRS179 |
PRS313 |
||||
---|---|---|---|---|---|---|---|
Cases, No. | OR (95% CI)b | P c | Cases, No. | OR (95% CI)b | P c | ||
PRS category, % | |||||||
<1 | 106 | 58 | 0.62 (0.44 to 0.89) | .009 | 60 | 0.63 (0.44 to 0.89) | .009 |
1-5 | 406 | 248 | 0.70 (0.58 to 0.84) | 1.43 × 10−4 | 235 | 0.70 (0.58 to 0.85) | 2.29 × 10−4 |
5-10 | 508 | 306 | 0.67 (0.56 to 0.79) | 2.25 × 10−6 | 309 | 0.72 (0.61 to 0.85) | 9.51 × 10−5 |
10-20 | 1020 | 687 | 0.74 (0.65 to 0.84) | 2.84 × 10−6 | 681 | 0.74 (0.65 to 0.84) | 3.52 × 10−6 |
20-40 | 2038 | 1598 | 0.89 (0.81 to 0.99) | .03 | 1560 | 0.84 (0.76 to 0.93) | 6.92 × 10−4 |
40-60 | 2038 | 1808 | 1.00 (Referent) | — | 1802 | 1.00 (Referent) | — |
60-80 | 2038 | 2033 | 1.10 (1.00 to 1.22) | .045 | 1952 | 1.03 (0.94 to 1.14) | .50 |
80-90 | 1019 | 1093 | 1.17 (1.04 to 1.32) | .008 | 1197 | 1.29 (1.15 to 1.45) | 1.22 × 10−5 |
90-95 | 508 | 645 | 1.42 (1.23 to 1.65) | 1.80 × 10−6 | 643 | 1.38 (1.20 to 1.60) | 1.28 × 10−5 |
95-99 | 406 | 593 | 1.60 (1.37 to 1.87) | 2.15 × 10−9 | 602 | 1.61 (1.38 to 1.87) | 1.32 × 10−9 |
>99 | 106 | 172 | 1.83 (1.39 to 2.40) | 1.56 × 10−5 | 200 | 2.01 (1.53 to 2.63) | 3.69 × 10−7 |
Continuous PRS per 1 SD | 10 193 | 9241 | 1.26 (1.22 to 1.30) | 2.59 × 10−45 | 9241 | 1.27 (1.23 to 1.31) | 4.23 × 10−49 |
AUC | 0.568 (0.56 to 0.576) | — | 0.571(0.562 to 0.579) | — |
AUCs were adjusted for study and the first 10 principal components. AUC = area under the receiver operating characteristic curve; CI = confidence interval; GBHS = Ghana Breast Health Study; OR = odds ratio; PRS = polygenic risk score.
Odds ratios were estimated using unconditional logistic regression model, adjusting for age, study, and the first 10 principal components in each consortium and in the GBHS and then combined using a fixed-effect meta-analysis with inverse variance weights.
Two-sided P values were Wald P value from fixed-effect meta-analysis.